These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34634184)

  • 1. Experimental evidence for proarrhythmic effects of nonsteroidal anti-inflammatory drugs in a sensitive whole-heart model.
    Wolfes J; Ellermann C; Bäumer S; Fehr M; Willy K; Wegner F; Leitz PR; Eckardt L; Frommeyer G
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130(1):103-109. PubMed ID: 34634184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model.
    Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Reinke F; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2021 Mar; 21(3):248-254. PubMed ID: 33125619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological Safety Profile of Antiestrogenic Therapies in the Isolated Rabbit Heart.
    Wolfes J; Ellermann C; Kirchner LM; Willy K; Rath B; Leitz PR; Eckardt L; Frommeyer G
    Pharmacology; 2022; 107(11-12):608-614. PubMed ID: 36174497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Treatment with Proton Pump Inhibitors and Cephalosporins Does Not Enhance QT-Associated Proarrhythmia in Isolated Rabbit Hearts.
    Wolfes J; Ellermann C; Burde S; Leitz P; Bögeholz N; Willy K; Fehr M; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2020 Dec; 20(6):531-538. PubMed ID: 32500385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.
    Frommeyer G; Ellermann C; Dechering DG; Kochhäuser S; Bögeholz N; Güner F; Leitz P; Pott C; Eckardt L
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1214-1219. PubMed ID: 27283775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmic potential of metoclopramide in a sensitive whole-heart model.
    Wolfes J; Ellermann C; Burde S; Fehr M; Eckardt L; Frommeyer G
    Basic Clin Pharmacol Toxicol; 2021 Jun; 128(6):741-746. PubMed ID: 33548156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
    Frommeyer G; Milberg P; Clauss C; Schmidt M; Ramtin S; Kaese S; Grundmann F; Grotthoff JS; Pott C; Eckardt L
    Europace; 2014 Aug; 16(8):1240-8. PubMed ID: 24696223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of physiological late Na
    El-Bizri N; Li CH; Liu GX; Rajamani S; Belardinelli L
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H236-H245. PubMed ID: 28971840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic.
    Hondeghem LM; Carlsson L; Duker G
    Circulation; 2001 Apr; 103(15):2004-13. PubMed ID: 11306531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological Profile of Different Antiviral Therapies in a Rabbit Whole-Heart Model.
    Wolfes J; Kirchner L; Doldi F; Wegner F; Rath B; Eckardt L; Ellermann C; Frommeyer G
    Cardiovasc Toxicol; 2024 Jul; 24(7):656-666. PubMed ID: 38851664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of late sodium current inhibition on cardiac electrophysiology parameters and ventricular arrhythmias in isolated Langendorff perfused rabbit hearts with short QT interval].
    Huang YW; Chen Y; Wang CY; Wu L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Nov; 50(11):1087-1093. PubMed ID: 36418277
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac electrophysiological effects of ibuprofen in dog and rabbit ventricular preparations: possible implication to enhanced proarrhythmic risk.
    Pászti B; Prorok J; Magyar T; Árpádffy-Lovas T; Györe B; Topál L; Gazdag P; Szlovák J; Naveed M; Jost N; Nagy N; Varró A; Virág L; Koncz I
    Can J Physiol Pharmacol; 2021 Jan; 99(1):102-109. PubMed ID: 32937079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.
    Ellermann C; Coenen A; Niehues P; Leitz P; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2020 Apr; 20(2):168-175. PubMed ID: 31302839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.
    Ellermann C; Wolfes J; Puckhaber D; Bögeholz N; Leitz P; Lange PS; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2019 Jun; 19(3):237-243. PubMed ID: 30515668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs.
    Ellermann C; Wolfes J; Eckardt L; Frommeyer G
    Europace; 2021 Jun; 23(6):828-836. PubMed ID: 33200170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.
    Qiu B; Wang Y; Li C; Guo H; Xu Y
    J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):160-171. PubMed ID: 30092655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.
    Kristóf A; Husti Z; Koncz I; Kohajda Z; Szél T; Juhász V; Biliczki P; Jost N; Baczkó I; Papp JG; Varró A; Virág L
    PLoS One; 2012; 7(12):e53255. PubMed ID: 23300901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.